<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en" article-type="correction">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">OL</journal-id>
<journal-title-group>
<journal-title>Oncology Letters</journal-title>
</journal-title-group>
<issn pub-type="ppub">1792-1074</issn>
<issn pub-type="epub">1792-1082</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/ol.2026.15867</article-id>
<article-id pub-id-type="publisher-id">OL-32-5-15867</article-id>
<article-categories>
<subj-group>
<subject>Corrigendum</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>[Corrigendum] Lysyl oxidase-like-1 enhances lung metastasis when lactate accumulation and monocarboxylate transporter expression are involved</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Lee</surname><given-names>Geum-Hwa</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Kim</surname><given-names>Do-Sung</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Chung</surname><given-names>Myung Ja</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Chae</surname><given-names>Soo-Wan</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Kim</surname><given-names>Hyung-Ryong</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Chae</surname><given-names>Han-Jung</given-names></name>
</contrib>
</contrib-group>
<pub-date pub-type="collection"><month>11</month><year>2026</year></pub-date>
<pub-date pub-type="epub"><day>16</day><month>09</month><year>2026</year></pub-date>
<volume>32</volume>
<issue>5</issue>
<elocation-id>512</elocation-id>
<permissions>
<copyright-statement>Copyright: &#x00A9; 2026 Lee et al.</copyright-statement>
<copyright-year>2026</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.</license-p></license>
</permissions>
</article-meta>
</front>
<body>
<p>Oncol Lett 2: <related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="corrected-article" vol="2" page="831" id="RA1" xlink:href="10.3892/ol.2011.353" ext-link-type="doi">831&#x2013;838</related-article>, 2011; DOI: 10.3892/ol.2011.353</p>
<p>Subsequently to the publication of the above article, an interested reader drew to the authors&#x0027; attention that, concerning the cellular invasion assay data shown in <xref rid="f3-ol-32-5-15867" ref-type="fig">Fig. 3A</xref> on p. 835, data shown in the &#x2018;LOCL-1 siRNA&#x2019; panel were strikingly similar to data that had already appeared in an article written by the same research group, which was published in the journal <italic>Oncogene</italic>.</p>
<p>After re-examining their original data, the authors were able to confirm that <xref rid="f3-ol-32-5-15867" ref-type="fig">Fig. 3</xref> had been assembled incorrectly in the above paper. A revised version of <xref rid="f3-ol-32-5-15867" ref-type="fig">Fig. 3</xref>, now showing the correct data for the &#x2018;LOCL-1 siRNA&#x2019; panel in <xref rid="f3-ol-32-5-15867" ref-type="fig">Fig. 3A</xref>, is shown on the next page. Note that the revision made to this figure has not led to any significant changes in either the results or the conclusions reported in this paper. The authors are grateful to the Editor of <italic>Oncology Letters</italic> for allowing them this opportunity to publish a Corrigendum, and all the authors agree with its publication; furthermore, they apologize to the readership for any inconvenience caused.</p>
</body>
<floats-group>
<fig id="f3-ol-32-5-15867" position="float">
<label>Figure 3.</label>
<caption><p>Endogenous LOXL-1 plays a significant role in the extracellular accumulation of lactate and the expression of its transporter, MCT1/2, in <italic>in vitro</italic> cancer metastasis. (A) HT1080 cells were transfected with non-specific or LOXL-1-specific siRNA and the expression of LOXL-1 was confirmed (upper panel). The invasion analysis was performed as in Fig. 2A. The 0.1&#x0025; crystal violet staining cells in the lower chamber are shown (A, lower panel). (B) The number was determined by counting cells in the lower wells (C). The width of the injury line was quantified at the indicated culturing periods, 0, 6, 12, 18 or 24 h. (D) Lactate in the medium was measured when non-specific and LOXL-1 siRNA-transfected cells were cultured for the indicated periods (12, 24, 36 or 48 h) (E and F) Western blotting was performed with anti-MCT1/2, MMP2/9, LOXL-1 or &#x03B2;-actin antibodies. (G) Zymography was performed for MMP2/9 activity. &#x002A;P&#x003C;0.05, significantly different from the non-specific siRNA-transfected condition. NSsi, non-specific siRNA.</p></caption>
<alt-text>Endogenous LOXL-1 plays a significant role in the extracellular accumulation of lactate and the expression of its transporter, MCT1/2, in in vitro cancer metastasis. (A) HT1080...</alt-text>
<graphic xlink:href="ol-32-05-15867-g00.tif"/>
</fig>
</floats-group>
</article>
